Your session is about to expire
← Back to Search
PRP in Hiatal Hernia Repair (PPR-HHR Trial)
PPR-HHR Trial Summary
This trial is testing whether using platelet-rich plasma (PRP) to repair a hiatal hernia is more effective than traditional surgery without PRP.
PPR-HHR Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.PPR-HHR Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have diabetes.I have had surgery to prevent acid reflux.I have taken antiplatelet medication within the last 10 days.I have used corticosteroids within a month before surgery.I have been treated for cancer or had active cancer in the past year.
- Group 1: PRP
- Group 2: No PRP
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What are the principal aims of this investigation?
"At the conclusion of this study, which is anticipated to span around one year, researchers will measure hernia recurrence via endoscopic methods or video esophagram. Additional aims include assessing GERD-HRQL by way of survey responses, determining dysphagia scores through analysis and reducing proton pump inhibitor use as an indication of efficacy."
Are there any openings within this trial for participants?
"Sadly, as per clinicaltrials.gov's records, this particular medical trial is not currently accepting participants. This study was initially posted on October 18th 2021 and the last update occurred 15 days ago in October 2022. However, there are still 223 other studies that invite patients to take part right now."
Who else is applying?
What state do they live in?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Why did patients apply to this trial?
Share this study with friends
Copy Link
Messenger